Menu
08/08/2003
UCF calls for clearer guidelines for HRT
The Ulster Cancer Foundation has called for clearer guidelines on the use of hormone replacement therapy (HRT) following a report that some kinds of (HRT) have a signicantly greater risk of breast cancer than others.
The Million Women Study, funded by Cancer Research UK, the NHS Breast Screening Programme and the Medical Research Council, confirmed that current and recent use of HRT increases a woman's chance of developing breast cancer and that the risk goes up with duration of use.
Current users of all types of HRT, including oestrogen-only, combined oestrogen-progestagen and tibolone, are at increased risk of breast cancer compared with women who have never used HRT. But the risk is substantially greater for users of combined preparations of HRT than for women on the other types.
Professor Valerie Beral, Director of the Cancer Research UK Epidemiology Unit and the lead author of the report, said: "We estimate that over the past decade use of HRT by UK women aged 50-64 has resulted in an extra 20,000 breast cancers, oestrogen-progestagen therapy accounting for 15,000 of these.
"Combined oestrogen-progestagen HRT is usually prescribed for women who still have a uterus, to avoid the increased risk of cancer of the uterus caused by oestrogen-only therapy.
"Since our results show a substantially greater increase in breast cancer with combined HRT, women need to weigh the increased risk of breast cancer caused by the addition of progestagen against the lowered risk of uterine cancer.
"Comparing the risks is by no means simple, and women may well want to discuss options with their doctor."
Scientists at the Cancer Research UK Epidemiology Unit in Oxford analysed data from over one million women between the ages of 50 and 64.
Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer those not on HRT.
The study also found that current HRT users may have an increased risk of death from breast cancer (22%) compared with women who have never had HRT. Though the reports' authors said more work was needed to confirm this figure as the results was of borderline statistical significance.
(MB/SP)
The Million Women Study, funded by Cancer Research UK, the NHS Breast Screening Programme and the Medical Research Council, confirmed that current and recent use of HRT increases a woman's chance of developing breast cancer and that the risk goes up with duration of use.
Current users of all types of HRT, including oestrogen-only, combined oestrogen-progestagen and tibolone, are at increased risk of breast cancer compared with women who have never used HRT. But the risk is substantially greater for users of combined preparations of HRT than for women on the other types.
Professor Valerie Beral, Director of the Cancer Research UK Epidemiology Unit and the lead author of the report, said: "We estimate that over the past decade use of HRT by UK women aged 50-64 has resulted in an extra 20,000 breast cancers, oestrogen-progestagen therapy accounting for 15,000 of these.
"Combined oestrogen-progestagen HRT is usually prescribed for women who still have a uterus, to avoid the increased risk of cancer of the uterus caused by oestrogen-only therapy.
"Since our results show a substantially greater increase in breast cancer with combined HRT, women need to weigh the increased risk of breast cancer caused by the addition of progestagen against the lowered risk of uterine cancer.
"Comparing the risks is by no means simple, and women may well want to discuss options with their doctor."
Scientists at the Cancer Research UK Epidemiology Unit in Oxford analysed data from over one million women between the ages of 50 and 64.
Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer those not on HRT.
The study also found that current HRT users may have an increased risk of death from breast cancer (22%) compared with women who have never had HRT. Though the reports' authors said more work was needed to confirm this figure as the results was of borderline statistical significance.
(MB/SP)
Related Northern Ireland News Stories
Click here for the latest headlines.
15 November 2024
Winter Vaccines: Get Boosted To Protect Yourself
The Public Health Agency (PHA) is urging eligible individuals in Northern Ireland to get their annual flu and COVID-19 vaccines as soon as possible. The agency highlights the significant benefits of vaccination in reducing severe illness and death, especially for those at high risk.
Winter Vaccines: Get Boosted To Protect Yourself
The Public Health Agency (PHA) is urging eligible individuals in Northern Ireland to get their annual flu and COVID-19 vaccines as soon as possible. The agency highlights the significant benefits of vaccination in reducing severe illness and death, especially for those at high risk.
09 September 2011
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
10 October 2001
Call for more information on smoking health risks
With this week focusing on women and cancer a local councillor has spoken out and has called for more information to be made to women about the risks of smoking to their health.
Call for more information on smoking health risks
With this week focusing on women and cancer a local councillor has spoken out and has called for more information to be made to women about the risks of smoking to their health.
05 December 2013
NI Highest Breast Cancer Survival In UK
Northern Ireland has the highest breast cancer survival rates in the UK and Ireland, according to research by Queen's University. The data for Northern Ireland was provided by the Queen’s Northern Ireland Cancer Registry to the EUROCARE 5 study. The research is part of a European-wide study into cancer survival rates.
NI Highest Breast Cancer Survival In UK
Northern Ireland has the highest breast cancer survival rates in the UK and Ireland, according to research by Queen's University. The data for Northern Ireland was provided by the Queen’s Northern Ireland Cancer Registry to the EUROCARE 5 study. The research is part of a European-wide study into cancer survival rates.
10 October 2011
Pink Lady Backs NI Cancer Research
A Saintfield woman, Noleen Adair, who knows about cancer, having discovered she had breast cancer at 22 to be faced with radical surgery and chemotherapy has been fundraising. Noleen refuses to put her life on hold and now, the charity she founded to help others facing breast cancer has presented a dazzling £50,000 to Friends of The Cancer Centre.
Pink Lady Backs NI Cancer Research
A Saintfield woman, Noleen Adair, who knows about cancer, having discovered she had breast cancer at 22 to be faced with radical surgery and chemotherapy has been fundraising. Noleen refuses to put her life on hold and now, the charity she founded to help others facing breast cancer has presented a dazzling £50,000 to Friends of The Cancer Centre.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
